Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 12 2012 000 083.7 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Brentuximabvedotin oder pharmazeutisch akzeptable Salze davon |
54 | Title of basic patent | TIGZ | AURISTATIN-KONJUGATE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON KREBS, EINER AUTOIMMUNKRANHEIT ODER EINER INFEKTIONSKRANKHEIT |
51 | IPC main class | ICM (ICMV) | A61K 39/395 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | C07K 16/46 (2006.01), C07K 16/30 (2006.01), C07K 16/12 (2006.01), C07K 5/06 (2006.01), C07K 5/02 (2006.01) |
94 | Start of term of protection | LB | Aug 1, 2023 |
94 | End of term of protection | LE | Oct 30, 2027 |
22 | DE application date | DAT | Oct 31, 2012 |
| Date of publication of application for a certificate | OT | Jan 24, 2013 |
| Date of publication of grant of certificate | PET | Jun 24, 2021 |
71/73 | Applicant/owner | INH | Seagen Inc., 21823 30th Drive SE, 98021 Bothell, WA, US |
74 | Representative | VTR | Boeters & Lieck, 80331 München, DE |
| Address for service | | Patentanwälte BOETERS & LIECK, 80331 München, DE |
| Due date | FT FG | Aug 31, 2025 Annual fee for the 23rd year
Patent fees |
| Patent division in charge | | 44 |
68 | DE file number of basic patent | GAKZ | 603 37 755.6 |
68 | EP file number of basic patent | GEAKZ | 03 77 2186.7 |
43 | Date of first publication | EVT | Jan 24, 2013 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/12/794/001 2012-10-25
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/12/794/001 2012-10-25
|
| Date of the first transfer into DPMAregister | EREGT | Jan 24, 2013 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 19, 2024 (Show all update days)(Hide all update days)- Aug 19, 2024
- St.36: changed (technical change)
- Jul 2, 2024; Aug 17, 2023; Apr 30, 2022; Jan 25, 2022; Jun 22, 2021; May 15, 2021; Mar 12, 2021; Mar 4, 2021; Feb 10, 2021; Jan 9, 2020; Jul 16, 2019; Jul 11, 2015; Jul 6, 2014; Jun 3, 2014; May 7, 2014; May 6, 2014; May 3, 2014; Mar 2, 2014; Oct 3, 2013; Sep 3, 2013; Aug 27, 2013; Aug 2, 2013; Jun 25, 2013; Jun 18, 2013; Mar 16, 2013
- Historical data not available for this/these date(s)
- Jan 24, 2013
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 2)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 9, 2021 |
71/73 | Applicant/owner | INH | Seagen Inc., 98021 Bothell, WA, US |
71/73 | Previous applicant/owner | INHF | Seattle Genetics, Inc., 98021 Bothell, Wash., US |
| Date of update of the procedure | REGT | Mar 4, 2021 |